Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension

Drug Discovery Today

Volumn 19, Issue 8, 2014, Pages 1241-1245

  West, James ^a   Austin, Eric ^a   Fessel, Joshua P ^a   Loyd, James ^a   Hamid, Rizwan ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2; ESTROGEN; ESTROGEN RECEPTOR ALPHA;

ALTERNATIVE RNA SPLICING; BREAST CANCER CELL LINE; CELL JUNCTION; CELL PROLIFERATION; CYTOSKELETON; ESTROGEN METABOLISM; FATTY ACID METABOLISM; GENE EXPRESSION; GENE MUTATION; HERITABLE PULMONARY ARTERIAL HYPERTENSION; HUMAN; LUNG BLOOD VESSEL; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; METABOLISM;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; HUMANS; HYPERTENSION, PULMONARY; SIGNAL TRANSDUCTION;

EID: 84906302558     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.04.015     Document Type: Review

References (46)

1. D.T. Dresdale et al. Primary pulmonary hypertension. I. Clinical and hemodynamic study Am. J. Med. 11 1951 686 705
2. E.K. Larkin et al. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension Am. J. Resp. Crit. Care Med. 186 2012 892 896
3. M. Germain et al. Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension Nat. Genet. 45 2013 518 521
4. L. Ma et al. A novel channelopathy in pulmonary arterial hypertension N. Eng. J. Med. 369 2013 351 361
5. E.D. Austin et al. Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension Circ. Cardiovasc. Genet. 5 2012 336 343
6. J.D. Cogan et al. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension Am. J. Resp. Crit. Care Med. 174 2006 590 598
7. R. Hamid et al. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele Hum. Mutat. 30 2009 649 654
8. R. Hamid et al. Transcripts from a novel BMPR2 termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension Clin. Genet. 77 2010 280 286
9. J. Lamb et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935
10. C. Flynn et al. Connectivity Map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance Am. J. Resp. Cell Mol. Biol. 47 2012 20 27
11. E. Spiekerkoetter et al. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension J. Clin. Invest. 123 2013 3600 3613
12. M. Lim et al. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids Am. J. Resp. Cell Mol. Biol. 31 2004 351 357
13. B.L. Rosenzweig et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins Proc. Natl. Acad. Sci. U. S. A. 92 1995 7632 7636
14. J. Cogan et al. Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance Circulation 126 2012 1907 1916
15. J.A. Johnson et al. Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension Am. J. Physiol. Lung Cell Mol. Physiol. 302 2012 L474 L484
16. R.D. Machado et al. Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension Hum. Mol. Genet. 12 2003 3277 3286
17. V.C. Foletta et al. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1 J. Cell Biol. 162 2003 1089 1098
18. J. West et al. Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions Am. J. Physiol. Lung Cell Mol. Physiol. 295 2008 L744 L755
19. R.D. Machado et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension Am. J. Hum. Genet. 68 2001 92 102
20. E.D. Austin et al. Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression Pulm. Circ. 1 2011 389 398
21. V.J. Burton et al. Bone morphogenetic protein receptor-II regulates pulmonary artery endothelial cell barrier function Blood 117 2010 333 340
22. V.A. de Jesus Perez et al. Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways J. Cell Biol. 184 2009 83 99
23. J.P. Fessel et al. Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming Pulm. Circ. 2 2012 201 213
24. K. Lane et al. Oxidative injury is a common consequence of BMPR2 mutations Pulm. Circ. 1 2011 72 83
25. V.J. Burton et al. Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II Blood 118 2011 4750 4758
26. A.J. Ferreira et al. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension Am. J. Resp. Crit. Care Med. 179 2009 1048 1054
27. D.B. Badesch et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry Chest 137 2010 376 387
28. K.M. Chin, and L.J. Rubin Pulmonary arterial hypertension J. Am. Coll. Cardiol. 51 2008 1527 1538
29. M. Humbert et al. Pulmonary arterial hypertension in France: results from a national registry Am. J. Resp. Crit. Care Med. 173 2006 1023 1030
30. K.E. Roberts et al. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease Am. J. Resp. Crit. Care Med. 179 2009 835 842
31. E.D. Austin et al. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females Eur. Resp. J. 34 2009 1093 1099
32. J.P. Fessel et al. Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension Pulm. Circ. 3 2013 564 577
33. M. Takahashi et al. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation J. Endocrinol. 199 2008 445 455
34. E.D. Austin et al. BMPR2 expression is suppressed by signaling through the estrogen receptor Biol. Sex Differ. 3 2012 6
35. 2+-dependent phospholipase A2 in estradiol-induced lysosome activation Am. J. Physiol. Cell Physiol. 283 2002 C1461 C1468
36. H.J. Durrington et al. Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II J. Biol. Chem. 285 2010 37641 37649
37. S. Umar et al. Estrogen paradox in pulmonary hypertension: current controversies and future perspectives Am. J. Resp. Crit. Care Med. 186 2012 125 131
38. L. Piao et al. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension J. Mol. Med. (Berl.) 91 2013 1185 1197
39. R.M. Tuder et al. Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension Am. J. Resp. Crit. Care Med. 185 2012 260 266
40. S.R. Plymate et al. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1 Oncogene 22 2003 1024 1034
41. D.R. Wise et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction Proc. Natl. Acad. Sci. U. S. A. 105 2008 18782 18787
42. S.L. Archer et al. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target Circulation 121 2010 2661 2671
43. A.J. Whittle et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions Cell 149 2012 871 885
44. J. West et al. A potential role for insulin resistance in experimental pulmonary hypertension Eur. Resp. J. 41 2013 861 871
45. M.E. Pugh et al. Unrecognized glucose intolerance is common in pulmonary arterial hypertension J. Heart Lung Transplant. 30 2011 904 911
46. M.E. Pugh et al. Hemodynamic improvement of pulmonary arterial hypertension after bariatric surgery: potential role for metabolic regulation Diabetes Care 36 2013 e32 e33